Pharma Sector Sees Rs. 29,268 Crore Increase Under PLI Scheme By May 2024

New Delhi: India’s Production Linked Incentive (PLI) scheme has stimulated significant investments in the pharmaceutical sector, aimed at strengthening domestic manufacturing and reducing import dependence, data from the Department of Pharmaceuticals (DoP) indicated.

The sector attracted Rs. 29,268 crore to expand production capacities and diversify the pharmaceutical base, the government said. In May, investments totalled Rs. 940 crore, marking a 3.32% increase from April 2024’s Rs. 28,328 crore. Production surged by 12.3% to Rs. 1,61,209 crore in May, up from Rs. 1,43,553 crore in the previous month.

Employment under the PLI for pharmaceuticals grew by 20%, reaching 71,763 individuals compared to April’s 59,768, with 261 manufacturing locations commissioned by May 2024, the government data showed. The bulk drugs segment saw investment rise to Rs. 3,737.33 crore from April’s Rs. 3,715 crore. Production increased by 10.3%, reaching Rs. 1,067.45 crore in May, with employment growing by 19% to 3,565 jobs compared to 2,994 in April. The segment now boasts 31 commissioned projects.

Simultaneously, the Medical Devices sector secured Rs. 958.72 crore in investments, enhancing production capacity to Rs. 5,986.56 crore. The establishment of 17 new manufacturing facilities turned the sector into a hub for innovation and technology, employing 5,396 people.

“The success of the PLI scheme extends beyond financial investments, with strategic implications for India’s pharmaceutical industry,” noted Dr. Vivek Desai, Founder & Managing Director of HOSMAC. “Reducing reliance on medical technology imports and boosting domestic production is vital as we head towards the Union Budget 2024-25,” he said.

Launched in 2021 with a financial outlay of Rs. 15,000 crore, the PLI scheme aims to provide incentives over six years to 55 selected applicants, including 20 Micro, Small, and Medium Enterprises (MSMEs). So far, 278 applications have been received, with 55 approved. In the bulk drugs segment, 48 out of 249 applications have received approval.

Related Posts

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

New Delhi: In a sweeping international crackdown, the Narcotics Control Bureau (NCB) and the US Drug Enforcement Administration (DEA) have dismantled the Indian nerve center of a massive transnational drug…

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Commissioner of Food Safety Tukaram Mundhe said inspections, consumer complaints and surveillance had repeatedly revealed violations Repeated violations of existing food safety regulations by manufacturers and sellers of health supplements…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines